Who is sponsoring NCT05386407?

NCT05386407 is sponsored by Teststation Praxis Dr. med Bielecki.

What condition does NCT05386407 study?

NCT05386407 studies Telemedicine, Pharynx, COVID-19.

Is NCT05386407 still recruiting?

NCT05386407 is currently status unknown. Last updated 12 April 2023.

Last reviewed 2023-04-12 · How we verify

NCT05386407

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telemedically Assisted Sampling of COVID-19 Patients - Is the Sampling Quality Sufficient

Status unknown NA Last updated 12 April 2023

What this trial tests

NA trial testing telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP) in Telemedicine in 170 participants. Status unknown.

Timeline

14 April 2022

Primary endpoint
30 October 2023

31 December 2025

Quick facts

Lead sponsor	Teststation Praxis Dr. med Bielecki
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	170
Start date	14 April 2022
Primary completion	30 October 2023
Estimated completion	31 December 2025
Sites	1 location across Switzerland

Drugs / interventions tested

telemedically guided oropharyngeal + nasal (OP+N) self-sampling (GSS) and nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP)

Conditions studied

Telemedicine — all drugs for Telemedicine →
Pharynx — all drugs for Pharynx →
COVID-19 — all drugs for COVID-19 →

Sponsor

Teststation Praxis Dr. med Bielecki

Who can join

18 and older, any sex, with Telemedicine or Pharynx. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) pandemic has resulted in more than 3.8 billion registered tests, 275 million positive cases, and 5 million deaths worldwide. Early and regular testing has been an important pillar of secondary prevention since the beginning. However, this pandemic has also fostered solutions in the form of e telemedicine with enormously increased applicability. The question of whether telemedically supervised testing with SARS-CoV-2 Rapid Antigen Tests is non-inferior to the same tests being carried out by trained personnel in test centers is still unanswered. With this study, the investigators aim to compare and evaluate the reliability and sampling quality of telemedically guided self-performed rapid tests for professional use compared to professional sampling by healthcare personnel. Our hypothesis is that, applying a strict standard operating procedure (SOP, attached), guided oropharyngeal + nasal (OP+N) self-sampling (GSS) is non-inferior to nasopharyngeal (NP) or OP+N sampling performed by health care professionals (HCP), and that guided OP+N sampling is superior to unsupervised OP+N self-sampling (USS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Telemedicine

Currently open trials in the same condition.

NCT07265037 — Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management · NA · recruiting
NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
NCT07124325 — Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care · NA · recruiting
NCT06942533 — Effect of Visual Feedback From the SpiroGym Mobile Application · NA · recruiting
NCT06980740 — Video-Tumorboard PLUS · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05386407 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Teststation Praxis Dr. med Bielecki
Last refreshed: 12 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05386407.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing